AstraZeneca PLC
AZN
$73.95
$0.861.18%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 7.11B | 5.40B | 5.53B | 4.93B | 7.08B |
Total Receivables | 15.17B | 14.82B | 13.09B | 13.55B | 12.62B |
Inventory | 6.47B | 5.88B | 5.29B | 5.66B | 5.67B |
Prepaid Expenses | -- | -- | 1.74B | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 195.00M | 45.00M | 183.00M | 16.00M | 28.00M |
Total Current Assets | 28.94B | 26.14B | 25.83B | 24.16B | 25.39B |
|
|||||
Total Current Assets | 28.94B | 26.14B | 25.83B | 24.16B | 25.39B |
Net Property, Plant & Equipment | 13.23B | 12.30B | 11.65B | 11.51B | 10.83B |
Long-term Investments | 21.22B | 21.13B | 21.03B | 21.14B | 21.06B |
Goodwill | 21.22B | 21.13B | 21.03B | 21.14B | 21.06B |
Total Other Intangibles | 37.93B | 37.55B | 37.18B | 39.39B | 39.43B |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 8.97B | 7.23B | 6.46B | 6.58B | 5.76B |
Total Assets | 112.42B | 106.25B | 104.04B | 104.92B | 104.34B |
|
|||||
Total Accounts Payable | 23.99B | 22.54B | 3.64B | 21.68B | 20.46B |
Total Accrued Expenses | -- | -- | 16.09B | -- | -- |
Short-term Debt | 2.03B | 1.39B | 330.00M | 1.24B | 3.05B |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 4.92B | 2.39B | 2.40B | 346.00M | 2.36B |
Total Finance Division Other Current Liabilities | 2.60B | 2.81B | 5.41B | 2.66B | 2.69B |
Total Other Current Liabilities | 2.60B | 2.81B | 5.41B | 2.66B | 2.69B |
Total Current Liabilities | 33.54B | 29.13B | 27.87B | 25.93B | 28.57B |
|
|||||
Total Current Liabilities | 33.54B | 29.13B | 27.87B | 25.93B | 28.57B |
Long-Term Debt | 24.71B | 26.74B | 26.62B | 28.92B | 27.29B |
Short-term Debt | 2.03B | 1.39B | 330.00M | 1.24B | 3.05B |
Capital Leases | 1.27B | 1.20B | 1.11B | 1.11B | 949.00M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 8.09B | 8.06B | 7.56B | 8.17B | 7.94B |
Total Liabilities | 67.61B | 65.12B | 63.16B | 64.12B | 64.74B |
|
|||||
Common Stock & APIC | 35.63B | 35.62B | 35.61B | 35.59B | 35.59B |
Retained Earnings | 7.02B | 3.36B | 7.23B | 3.14B | 1.85B |
Treasury Stock & Other | 2.07B | 2.05B | -2.06B | 1.99B | 2.08B |
Total Common Equity | 44.72B | 41.04B | 40.79B | 40.72B | 39.51B |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 44.72B | 41.04B | 40.79B | 40.72B | 39.51B |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 91.00M | 92.00M | 85.00M | 86.00M | 86.00M |
Total Equity | 44.81B | 41.13B | 40.87B | 40.81B | 39.60B |
|